Results 231 to 240 of about 38,942 (318)

Comparing the effectiveness of treating branch retinal vein occlusion with a novel one and stepped pro re nata treatment protocol. [PDF]

Medicine (Baltimore)
Chen PJ, Hsu AY, Lai CT, Lin CJ, Hsia NY, Chen WL, Tien PT, Lin JM, Chen SN, Tsai YY.   +9 more
europepmc   +1 more source

Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration

, 2010
Izabela Mitrut, Paul Y. Chua, Tariq Aslam, A Vani, A-M Ambrecht, B Dhillon   +5 more
openalex   +1 more source

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial

JAMA pediatrics, 2018
A. Stahl, T. Krohne, N. Eter, I. Oberacher-Velten, R. Guthoff, S. Meltendorf, O. Ehrt, S. Aisenbrey, J. Roider, H. Gerding, C. Jandeck, Lois E. H. Smith, J. M. Walz   +12 more
semanticscholar   +1 more source

Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration. [PDF]

J Ophthalmol
Xiaodong L, Xia C, Xuewei Q, Dandan W, Yi Y, Zhilin L.   +5 more
europepmc   +1 more source

PSS20 COST-UTILITY ANALYSIS OF A PRN (AS NEEDED) TREATMENT SCHEDULE WITH RANIBIZUMAB (LUCENTIS®) IN WET AMD BASED ON CLINICAL EVIDENCE

, 2010
K Moeremans, Laetitia Gerlier, Paul Mitchell, Meghan Gallagher, G. Vincze   +4 more
openalex   +1 more source

Evaluation of XSB-001 (Ranibizumab Biosimilar) Physicochemical and Biological Stability in Prepared Syringes for Intravitreal Injection. [PDF]

Adv Ther
Björnestedt R, Waters S, Paišytė A, Furlan F, Wanner C.   +4 more
europepmc   +1 more source

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

Ophthalmology (Rochester, Minn.), 2012
Daniel F. Martin, M. Maguire, S. Fine, G. Ying, G. Jaffe, J. Grunwald, C. Toth, Maryann Redford, F. Ferris   +8 more
semanticscholar   +1 more source

A case of atypical retinopathy of prematurity with coexisting occlusive vasculitis. [PDF]

Am J Ophthalmol Case Rep
Jang JH.
europepmc   +1 more source

Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems. [PDF]

Ophthalmol Ther
Banerjee M, Moharana S, Padhy SK.
europepmc   +1 more source

Changes of choroidal thickness and choroidal vascularity index in patients with macular edema secondary to branch retinal vein occlusion after intravitreal ranibizumab. [PDF]

Int J Retina Vitreous
Qi Y, Scotland DH, Zhang C, Xu J.
europepmc   +1 more source